Rchr
J-GLOBAL ID:201801009136105812
Update date: Jul. 14, 2024
Tsutomu Kawaguchi
Tsutomu Kawaguchi
Affiliation and department:
Research field (1):
Tumor biology
Research theme for competitive and other funds (1):
- 2018 - 2020 Immune cytolytic activity to assess anti-tumor immunity associates with intra-tumoral genetic heterogeneity and impacts clinical outcomes in solid tumor
Papers (56):
-
Masato Takahashi, Eriko Tokunaga, Joji Mori, Yoshinori Tanizawa, Jan-Stefan van der Walt, Tsutomu Kawaguchi, Matthew P Goetz, Masakazu Toi. Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Breast cancer (Tokyo, Japan). 2022. 29. 1. 174-184
-
Hiroyuki Inoue, Tsutomu Kawaguchi, Hisashi Ikoma, Ryo Morimura, Yusuke Yamamoto, Toshiya Ochiai, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, et al. Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy. Journal of surgical oncology. 2021. 124. 5. 791-800
-
Aparna Maiti, Ichiro Okano, Masanori Oshi, Maiko Okano, Wanqing Tian, Tsutomu Kawaguchi, Eriko Katsuta, Kazuaki Takabe, Li Yan, Santosh Patnaik, et al. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs. Cancers. 2021. 13. 11
-
Kenichi Inoue, Norikazu Masuda, Hiroji Iwata, Masato Takahashi, Yoshinori Ito, Yasuo Miyoshi, Takahiro Nakayama, Hirofumi Mukai, Jan-Stefan van der Walt, Joji Mori, et al. Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy. Breast cancer (Tokyo, Japan). 2021. 28. 5. 1038-1050
-
Masanori Oshi, Tsutomu Kawaguchi, Li Yan, Xuan Peng, Qianya Qi, Wanqing Tian, Amy Schulze, Kerry-Ann McDonald, Sumana Narayanan, Jessica Young, et al. Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer. American journal of cancer research. 2021. 11. 7. 3628-3644
more...
MISC (61):
-
生駒久視, 川口耕, 庄田勝俊, 有田智洋, 小菅敏幸, 小西博貴, 森村玲, 村山康利, 塩崎敦, 栗生宜明, et al. 十二指腸損傷縫合部の縫合不全を考える. 日本腹部救急医学会雑誌. 2019. 39. 2. 324
-
森村玲, 生駒久視, 工藤道弘, 庄田勝俊, 川口耕, 有田智洋, 小菅敏幸, 小西博貴, 村山康利, 塩崎敦, et al. Difficulty scoring systemを用いた腹腔鏡下膵切除における手術難度の検証. 日本外科学会定期学術集会(Web). 2019. 119th. ROMBUNNO.PS-080-4 (WEB ONLY)
-
川口耕, 有田智洋, 小菅敏幸, 小西博貴, 森村玲, 村山康利, 塩崎敦, 栗生宜明, 生駒久視, 窪田健, et al. 固形癌における革新的ゲノム解析法を用いた免疫微小環境ならびに腫瘍不均一性の解明. 日本外科学会定期学術集会(Web). 2019. 119th. ROMBUNNO.WS-9-8 (WEB ONLY)
-
井上博之, 生駒久視, 川口耕, 森村玲, 工藤道弘, 庄田勝俊, 有田智洋, 小菅敏幸, 小西博貴, 村山康利, et al. 大腸癌肝転移症例におけるオリゴ型転移指標の臨床的意義の検討. 日本外科学会定期学術集会(Web). 2019. 119th. ROMBUNNO.PS-173-2 (WEB ONLY)
-
生駒久視, 川口耕, 森村玲, 庄田勝俊, 有田智洋, 小菅敏幸, 小西博貴, 村山康利, 塩崎敦, 大辻英吾. 腹腔鏡下肝切除導入が周術期感染症発症に与えた影響について. 日本外科感染症学会雑誌(Web). 2018. 15. 5. 475
more...
Professional career (1):
Work history (5):
- 2019/04 - 現在 Kyoto Prefectural University of Medicine
- 2018/04 - 2019/03 Kyoto Prefectural University of Medicine
- 2016/04 - 2018/03 Roswell Park Cancer Institute Surgical Oncology/Molecular Cell Biology Researech Fellow
- 2011/04 - 2015/03 Kyoto Prefectural University of Medicine Graduate School of Medical Science
- 2005/04 - 2011/03 Kyoto Prefectural University of Medicine
Return to Previous Page